Optimization of Patients' Physical and Mental Status Prior to Colorectal Cancer Surgery (OPT)
Primary Purpose
Complication,Postoperative, ERAS
Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Optimisation
Sponsored by
About this trial
This is an interventional prevention trial for Complication,Postoperative focused on measuring ERAS, RCT, Optimisation
Eligibility Criteria
Inclusion Criteria:
- All patients, 18 years or older, with strong suspicion of colorectal cancer
Exclusion Criteria:
- Patients with dementia with severe cognitive impairment
Sites / Locations
- Ulf Oskar GustafssonRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention arm
Control arm
Arm Description
Optimisation: Diet, organised exercise, psychosocial support
Current standard preparation before surgery
Outcomes
Primary Outcome Measures
Serious complications
Can preoperative optimization change the proportion of serious complications after surgery (defined according to Clavien 3b-5) in intervention vs. control arm.
) in intervention vs. control arm
Secondary Outcome Measures
Reoperations
Change of proportion of reoperations in intervention vs. control arm
Length of stay (LOS)
Change of LOS (days) in intervention vs. control arm
Working capacity
Change of walking distance (meter) in intervention vs. control arm (6 minute walk test)
Weight loss
Change of weight loss (kg) in intervention vs. control arm
Psychosocial status
Change of points in Hospital and Anxiety scale (HAD) in intervention vs. control arm
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04909567
Brief Title
Optimization of Patients' Physical and Mental Status Prior to Colorectal Cancer Surgery
Acronym
OPT
Official Title
Optimization of Patients' Physical and Mental Status Prior to Colorectal Cancer Surgery -a Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 26, 2021 (Actual)
Primary Completion Date
September 1, 2025 (Anticipated)
Study Completion Date
September 1, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Colorectal cancer is one of the most common cancers globally. A majority are operated on for the purpose of cure. Complications after surgery are common, involve long length of stay and increase the risk of later recurrence of cancer. Optimization of physical and mental function before surgery can reduce the risk of complications and provide a faster recovery. However, a standardized form for how optimization should be performed does not exist.
At Danderyd Hospital, Stockholm, Sweden, we are starting up an optimization center where patients are offered optimizing measures while waiting for surgery. This form of structured treatment has not been studied before and we therefore want to investigate outcomes in a randomized study.
All patients with colorectal cancer who are being examined for surgery are offered participation in the study. Randomization of 518 patients in to either an intervention group where the patients; are optimized for concomitant diseases, treated for malnutrition and overconsumption of alcohol and tobacco, undergoes an exercise program and receives psychosocial support before surgery, or a control group where patients are prepared for surgery according to current routines. Primary outcome is the difference in severe complications between the groups. Secondary outcome is difference in length of stay as well as fitness and mental well-being before and 30 days after the operation.If optimization before surgery reduces complications and shortens length of stay, the model can also be used by other operating specialties. This may result in a great improvement for the healthcare in general.
Detailed Description
A randomized controlled, unblinded study with block stratification for surgical procedures.
Intervention arm:
All patients in the intervention group will be treated in an "optimization center" which constitutes its own physical location at the hospital and functions as a day care unit staffed with doctors, contact nurses, physiotherapists, ERAS nurses and dietitians. An expert team of cardiologists, physiologists, renal physicians and endocrinologists are attached to the unit.
Day 1. (2-12 weeks before the operation). Multipel testing: Clinical status, ASA score, NSQIP score. Alcohol and Smoke score tests. Nutritional score. 6 minute walk test. Psychiatric score tests. If mortality risk >5% according to NSQIP, low performance on walk test, chair stand test. ASA 3-4, HbA1c >50 for non diabetics, >60 for diabetics or (GFR <45) = special attention from the expert team.
Day 2 until one week before surgery:
Home exercise 5 days / week. Organised (physiotherapist) exercise 2 days / week. Dietprogram with close follow-up. Psychosocial support. Smoking and alcohol cessation program
The week before surgery: The same tests as day 1. 30 days posted: The same tests as day 1.
Controlarm: The same tests as for the intervention group, day 1, the week before surgery and 30 days post. No interventions during the period.
The international ERAS database will be used to record data in the study. Consecutive registration of over 300 perioperative variables on each individual patient.
Examples of these variables are basic patient characteristics, preoperative variables such as information before surgery, laxation, nutrition, fluid intake, anemia and glucose optimization. Intraoperative variables such as body temperature, fluid supply, anesthesia method, bleeding, operation time and gastric tube. Postoperative variables such as catheter removal, nutrition, mobilization, nausea, paralytic ileus, specified complications, reoperations and length of stay after surgery. Compliance with the ERAS protocol will be registered.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complication,Postoperative, ERAS
Keywords
ERAS, RCT, Optimisation
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
518 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention arm
Arm Type
Experimental
Arm Description
Optimisation:
Diet, organised exercise, psychosocial support
Arm Title
Control arm
Arm Type
No Intervention
Arm Description
Current standard preparation before surgery
Intervention Type
Behavioral
Intervention Name(s)
Optimisation
Intervention Description
Defined optimisation
Primary Outcome Measure Information:
Title
Serious complications
Description
Can preoperative optimization change the proportion of serious complications after surgery (defined according to Clavien 3b-5) in intervention vs. control arm.
) in intervention vs. control arm
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Reoperations
Description
Change of proportion of reoperations in intervention vs. control arm
Time Frame
30 days
Title
Length of stay (LOS)
Description
Change of LOS (days) in intervention vs. control arm
Time Frame
30 days
Title
Working capacity
Description
Change of walking distance (meter) in intervention vs. control arm (6 minute walk test)
Time Frame
2-12 weeks
Title
Weight loss
Description
Change of weight loss (kg) in intervention vs. control arm
Time Frame
2-12 weeks
Title
Psychosocial status
Description
Change of points in Hospital and Anxiety scale (HAD) in intervention vs. control arm
Time Frame
2-12 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients, 18 years or older, with strong suspicion of colorectal cancer
Exclusion Criteria:
Patients with dementia with severe cognitive impairment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Klas Pekkari, MD, PhD,
Phone
46707799817
Email
klas.pekkari@sll.se
First Name & Middle Initial & Last Name or Official Title & Degree
Helene Vibom, nurse
Phone
Danderyd
Email
helene.vibom@sll.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ulf Gustafsson, MD, PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Josefin Karlsson, Nurse
Organizational Affiliation
Karolinska Institutet
Official's Role
Study Chair
Facility Information:
Facility Name
Ulf Oskar Gustafsson
City
Stockholm
ZIP/Postal Code
18288
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ulf Gustafsson
Phone
46706073828
Email
ulf.o.gustafsson@regionstockholm.se
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data Availability Statement
Due to Swedish legal restrictions and the current ethical approval for the study, data is not publicly available to share, but the research group can provide descriptive data in table form.
Learn more about this trial
Optimization of Patients' Physical and Mental Status Prior to Colorectal Cancer Surgery
We'll reach out to this number within 24 hrs